Inactive Instrument

Concordia International Corp Stock Toronto S.E.

Equities

Duration

Period

Style

Aberdeen Asset Management : Equity, Macro hedge funds look to bounce back from a tough year	16-12-23	RE
Exclusive: Endo considers sale of Paladin Labs to Knight Therapeutics - sources	16-11-04	RE
Exclusive: Canada drugmaker Cipher mulls sale - sources	16-10-31	RE
Exclusive: Canada drugmaker Cipher mulls sale - sources	16-10-31	RE
Concordia International : Canadian drugmaker Concordia says CEO to step down	16-10-21	RE
Drug maker Concordia in talks to sell equity stake: sources	16-10-03	RE
Concordia Healthcare : TRLPC: Valeant’s falling secondary loan price pulls pharma companies down	15-10-22	RE
Canadian Natural Resources : Slumping oil, China worries hit TSX's resource stocks	15-10-19	RE
Concordia Healthcare : boosts drug portfolio with $1.9 billion deal	15-09-08	RE

Concordia International Corp. : Adds European Pharmaceutical Industry Expert to its Board of Directors	18-10-29	PR
Concordia International Corp. : Announces Addition of Pharmaceutical Industry Expert to its Board of Directors	18-10-15	PR
Concordia International Corp. : Announces Intention To Rebrand As ADVANZ PHARMA Following Its Successful Recapitalization	18-10-09	PR
Concordia International Corp. : Announces Special Meeting of Shareholders To Approve Name Change	18-10-05	PR
Concordia International Corp. : Provides Further Update On Its Recently Completed Recapitalization Transaction and the Issue Price of its Private Placement	18-09-12	PR

Concordia International : discute de la vente d'une participation minoritaire-sces	16-10-03
Concordia Healthcare : rachète Amdipharm pour $1,9 md	15-09-08
Les valeurs à suivre mardi 8 septembre 2015 à Wall Street -	15-09-08
CONCORDIA HEALTHCARE : s'offre Amdipharm Mercury	15-09-08

Sector